bioAffinity Technologies BIAF

bioAffinity Technologies increases stock offering

Securities offering

Form
424B5
Filed
Importance
Routine
  1. Up to $5,228,226 common stock offered
  2. 114,672 shares sold for $1.3M since May 2025
  3. Additional $3.4M offered under Sales Agreement

Written from the 424B5 on EDGAR. Check the filing before you rely on it.

Get an email when bioAffinity Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.